Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Conditions:   Transsexualism;   Transgenderism;   Adiposity;   Eating Behavior;   Arterial Stiffness;   Microangiopathy Intervention:   Sponsor:   University of Leipzig Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2021 Category: Research Source Type: clinical trials

Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer
Condition:   Neoplasm of Breast Intervention:   Other: Therapeutic Education and Nursing Support Program for Supportive Care Sponsors:   Centre Hospitalier Emile Roux;   University Hospital, Clermont-Ferrand;   Walisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2021 Category: Research Source Type: clinical trials

Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
Conditions:   Hiv;   Prophylaxis;   Transgender Interventions:   Drug: Truvada alone;   Drug: Truvada plus Leuprolide;   Drug: Truvada plus Estradiol 1 mg;   Drug: Truvada plus Estradiol 6 mg;   Drug: Estradiol 6 mg alone Sponsors:   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2021 Category: Research Source Type: clinical trials

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer
Condition:   The Neoadjuvant Therapy Interventions:   Drug: Ribocyclib, fulvestrant, triptorelin;   Drug: Doxorubicin, cyclophosphamide, paclitaxel Sponsor:   Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2021 Category: Research Source Type: clinical trials

A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
Condition:   Breast Neoplasms Interventions:   Drug: Abemaciclib;   Drug: Standard Adjuvant ET;   Drug: Placebo Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2021 Category: Research Source Type: clinical trials